DAPT(DUAL ANTIPLATELET THERAPY)

Clinical trials for DAPT(DUAL ANTIPLATELET THERAPY) explained in plain language.

Never miss a new study

Get alerted when new DAPT(DUAL ANTIPLATELET THERAPY) trials appear

Sign up with your email to follow new studies for DAPT(DUAL ANTIPLATELET THERAPY), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

Heart scan could let High-Risk patients stop risky blood thinners early

Disease control Completed

This study tested if diabetic patients at high risk of bleeding could safely stop taking two blood-thinning drugs (DAPT) early after getting a heart stent. Doctors used a high-resolution scan (OCT) to check if the artery had healed enough one month after the procedure. If it had,…

Matched conditions: DAPT(DUAL ANTIPLATELET THERAPY)

Phase: NA • Sponsor: Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

DAPT(DUAL ANTIPLATELET THERAPY)

Get alerted when new DAPT(DUAL ANTIPLATELET THERAPY) trials appear

Heart scan could let High-Risk patients stop risky blood thinners early